CLASS II Device recall · Reported 14 May 2014 · FDA Enforcement Report

Medtronic SynchroMed¿ II Implantable Drug Infusion Pump recalled

Medtronic Neuromodulation is recalling Medtronic SynchroMed¿ II Implantable Drug Infusion Pump, distributed nationwide in the US. The recall was initiated on 26 Feb 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesThis Medical Device Correction notification affects all SynchroMed II pumps.
Quantity recalled195,198 pumps (146,435 US, 48,763 OUS)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1570-2014
FDA event ID
67720
Recalling firm
Medtronic Neuromodulation, Minneapolis, MN
Classification
Class II
Status
Terminated
Recall initiated
26 Feb 2014
FDA classified
8 May 2014
Reported
14 May 2014
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons

Timeline

26 Feb 2014Recall initiated by company
8 May 2014Classified by FDA+71 days
14 May 2014Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

This recall provides important new information regarding overinfusion associated with the Medtronic SynchroMed II Implantable Pump. Overinfusion can result in a life-threatening overdose and can also result in drug withdrawal due to premature emptying of the pump. Due to the low reported rate of occurrence of this issue and the inability to predict which pumps may be at risk, Medtronic is not re

Product as listed by the FDA

Medtronic SynchroMed¿ II Implantable Drug Infusion Pump, Model 8637-20, 8637-40. The implantable Medtronic SynchroMed II programmable pumps are part of an infusion system that stores and delivers a prescribed drug to a specific site. The implanted infusion system consists of a SynchroMed II pump and a catheter.

Where it was distributed

Worldwide Distribution - All states in USA. OUS: List not provided at this time.

Nationwide

Questions about this recall

Why was it recalled?

This recall provides important new information regarding overinfusion associated with the Medtronic SynchroMed II Implantable Pump. Overinfusion can result in a life-threatening overdose and can also result in drug withdrawal due to premature emptying of the pump. Due to the low reported rate of occurrence of this issue and the inability to predict which pumps may be at risk, Medtronic is not re

Which lots are affected?

This Medical Device Correction notification affects all SynchroMed II pumps.

Where was it sold?

Worldwide Distribution - All states in USA. OUS: List not provided at this time.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medtronic Neuromodulation

All 86

Other Heart & Vascular Devices recalls

All 6,199